Multidrug resistance: molecular biology and clinical relevance.
作者信息
Rothenberg M, Ling V
机构信息
Division of Cancer Treatment, National Cancer Institute, Bethesda, MD.
出版信息
J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.
PMID:2567355
Abstract
摘要
相似文献
1
Multidrug resistance: molecular biology and clinical relevance.
J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.
2
Multidrug resistance in leukemia.白血病中的多药耐药性。
Cancer Treat Res. 1993;64:269-93. doi: 10.1007/978-1-4615-3086-2_13.
3
Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
J Natl Cancer Inst. 1989 Jun 21;81(12):910-3. doi: 10.1093/jnci/81.12.910.
4
Multidrug resistance: a novel class of membrane-associated transport proteins is identified.多重耐药性：一类新的膜相关转运蛋白被鉴定出来。
Cancer Invest. 1991;9(5):563-9. doi: 10.3109/07357909109018954.
5
Drug resistance and cancer.耐药性与癌症
Adv Exp Med Biol. 1993;330:287-305. doi: 10.1007/978-1-4615-2926-2_20.
6
Multidrug resistance in human cancer.人类癌症中的多药耐药性。
Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.
7
Multidrug resistance due to P-glycoprotein.
Hosp Pract (Off Ed). 1990 Apr 15;25(4):67-72, 74, 77. doi: 10.1080/21548331.1990.11703935.
8
Multidrug resistance in cancer.癌症中的多药耐药性。
BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148.
9
The clinical relevance of multidrug resistance.多重耐药性的临床相关性。
Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.
10
The cell biology of multiple drug resistance.
Biochem Pharmacol. 1987 Sep 15;36(18):2879-87. doi: 10.1016/0006-2952(87)90198-5.
引用本文的文献
1
Multifunctional layered black phosphorene-based nanoplatform for disease diagnosis and treatment: a review.用于疾病诊断与治疗的多功能层状黑磷基纳米平台综述
Front Optoelectron. 2020 Dec;13(4):327-351. doi: 10.1007/s12200-020-1084-1. Epub 2020 Nov 26.
2
A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells.一种新型合成二氢茚并[1,2-b]吲哚衍生物（LS-2-3j）逆转了癌细胞中 ABCB1 和 ABCG2 介导的多药耐药性。
Molecules. 2018 Dec 10;23(12):3264. doi: 10.3390/molecules23123264.
3
Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy.甲氨蝶呤抑制人黑色素瘤细胞系的活力，并增强Fas/Fas配体表达、细胞凋亡及对α干扰素的反应：联合治疗应用的理论依据
Arch Biochem Biophys. 2014 Dec 1;563:101-7. doi: 10.1016/j.abb.2014.04.019. Epub 2014 May 23.
4
Emerging role for drug transporters at the blood-testis barrier.药物转运体在血睾屏障中的新作用。
Trends Pharmacol Sci. 2011 Feb;32(2):99-106. doi: 10.1016/j.tips.2010.11.007. Epub 2010 Dec 17.
5
Investigation of multidrug resistance in cultured human renal cell carcinoma cells by 31P-NMR spectroscopy and treatment survival assays.利用31P核磁共振波谱和治疗存活分析研究培养的人肾癌细胞中的多药耐药性。
MAGMA. 2005 Jul;18(3):144-61. doi: 10.1007/s10334-005-0107-7. Epub 2005 Jun 23.
6
Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.器官特异性转移环境对肿瘤细胞基因表达和表型的调控
Cancer Metastasis Rev. 1995 Dec;14(4):323-38. doi: 10.1007/BF00690601.
7
Monitoring of chemotherapy-induced morphonuclear modifications by means of digital cell-image analysis.通过数字细胞图像分析监测化疗诱导的形态核改变。
J Cancer Res Clin Oncol. 1993;119(9):533-40. doi: 10.1007/BF01686463.
8
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Cancer Chemother Pharmacol. 1994;34(2):96-102. doi: 10.1007/BF00685925.
9
P glycoprotein (P-gp) and drug resistance--time for reappraisal?P糖蛋白（P-gp）与耐药性——是时候重新评估了吗？
Br J Cancer. 1993 Apr;67(4):641-3. doi: 10.1038/bjc.1993.119.
10
Multidrug resistance in cancer chemotherapy.
Invest New Drugs. 1994;12(1):1-13. doi: 10.1007/BF00873229.
Zotero 插件